Literature DB >> 26260198

Pluripotent Stem Cells and Skeletal Regeneration--Promise and Potential.

Joy Y Wu1.   

Abstract

The bone is a regenerative tissue, capable of healing itself after fractures. However, some circumstances such as critical-size defects, malformations, and tumor destruction may exceed the skeleton's capacity for self-repair. In addition, bone mass and strength decline with age, leading to an increase in fragility fractures. Therefore, the ability to generate large numbers of patient-specific osteoblasts would have enormous clinical implications for the treatment of skeletal defects and diseases. This review will highlight recent advances in the derivation of pluripotent stem cells, and in their directed differentiation towards bone-forming osteoblasts.

Entities:  

Mesh:

Year:  2015        PMID: 26260198      PMCID: PMC4560658          DOI: 10.1007/s11914-015-0285-9

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  91 in total

1.  A fresh look at iPS cells.

Authors:  Shinya Yamanaka
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

2.  Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction.

Authors:  Katsuhisa Tashiro; Mitsuru Inamura; Kenji Kawabata; Fuminori Sakurai; Koichi Yamanishi; Takao Hayakawa; Hiroyuki Mizuguchi
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

3.  A chemical platform for improved induction of human iPSCs.

Authors:  Tongxiang Lin; Rajesh Ambasudhan; Xu Yuan; Wenlin Li; Simon Hilcove; Ramzey Abujarour; Xiangyi Lin; Heung Sik Hahm; Ergeng Hao; Alberto Hayek; Sheng Ding
Journal:  Nat Methods       Date:  2009-10-18       Impact factor: 28.547

4.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

5.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.

Authors:  Danwei Huangfu; Kenji Osafune; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Shuibing Chen; Whitney Muhlestein; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-10-12       Impact factor: 54.908

6.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Authors:  Dohoon Kim; Chun-Hyung Kim; Jung-Il Moon; Young-Gie Chung; Mi-Yoon Chang; Baek-Soo Han; Sanghyeok Ko; Eungi Yang; Kwang Yul Cha; Robert Lanza; Kwang-Soo Kim
Journal:  Cell Stem Cell       Date:  2009-05-28       Impact factor: 24.633

7.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

8.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

9.  Transcriptional signature and memory retention of human-induced pluripotent stem cells.

Authors:  Maria C N Marchetto; Gene W Yeo; Osamu Kainohana; Martin Marsala; Fred H Gage; Alysson R Muotri
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  3 in total

1.  In Vivo Rescue of the Hematopoietic Niche By Pluripotent Stem Cell Complementation of Defective Osteoblast Compartments.

Authors:  Rhiannon Chubb; James Oh; Alyssa K Riley; Takaharu Kimura; Sean M Wu; Joy Y Wu
Journal:  Stem Cells       Date:  2017-08-02       Impact factor: 6.277

2.  Pluripotent stem cells as a source of osteoblasts for bone tissue regeneration.

Authors:  Hui Zhu; Takaharu Kimura; Srilatha Swami; Joy Y Wu
Journal:  Biomaterials       Date:  2018-02-05       Impact factor: 12.479

3.  3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway.

Authors:  Ning Wang; Xiajing Li; Zhiyong Zhong; Yaqi Qiu; Shoupei Liu; Haibin Wu; Xianglian Tang; Chuxin Chen; Yingjie Fu; Qicong Chen; Tingting Guo; Jinsong Li; Shuai Zhang; Mark A Zern; Keqiang Ma; Bailin Wang; Yimeng Ou; Weili Gu; Jie Cao; Honglin Chen; Yuyou Duan
Journal:  J Nanobiotechnology       Date:  2021-12-20       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.